Canada vs Kenya: Previously treated cases tested for RR-/MDR-TB
Canada
88.0%
in 2024
Kenya
87.0%
in 2024
Canada rank
90th
Kenya rank
92nd
Previously treated cases tested for RR-/MDR-TB over time
- Canada
- Kenya
How they compare
Canada currently reports 88.0% against 87.0% in Kenya, a difference of 1.0%.
The two have swapped places 2 times across 15 shared years of data; in 2006 it was Canada ahead.
Canada ranks 90th and Kenya ranks 92nd of 180 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 77.8% | 29.5% | 48.2% | Canada |
| 2010s | 76.3% | 37.2% | 39.0% | Canada |
| 2020s | 78.8% | 73.8% | 5.0% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Canada or Kenya?
- Canada, at 88.0% against 87.0% in Kenya as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Canada and Kenya?
- 1.0%, with Canada ahead.
- How many years of comparable data are there for Canada and Kenya?
- 15 years are reported by both, from 2006 to 2024.
- How do Canada and Kenya rank globally for previously treated cases tested for rr-/mdr-tb?
- Canada ranks 90th and Kenya ranks 92nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.